Exploring Virtual Reality Adventure Training Exergaming
V-RATE
1 other identifier
interventional
40
1 country
1
Brief Summary
The current project aims to design and implement an 8-week Virtual Reality Adventure Therapy Exergaming (V-RATE) intervention focused on women veterans. A randomized controlled trial using a repeated measure design with a 1-month follow-up assessment will be employed to examine effects on physical and mental health outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 7, 2022
CompletedFirst Submitted
Initial submission to the registry
September 28, 2022
CompletedFirst Posted
Study publicly available on registry
October 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
October 29, 2025
October 1, 2025
4 years
September 28, 2022
October 27, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in depression from baseline to week 6-8 and one-month follow-up (Week 12)
Depression will be measured by self-report using the nine-item Patient Health Questionnaire-9 (PHQ-9).
Baseline, Week 6-8, Week 12
Secondary Outcomes (7)
Anxiety change from baseline to week 6-8 and one-month follow-up (Week 12)
Baseline, post-training, Week 12
Posttraumatic Stress change from baseline to week 8 and one-month follow-up (Week 12)
Baseline, post-training, Week 12
Cognitive Function change from baseline to week 8 and one-month follow-up (Week 12)
Baseline, post-training, Week 12
Health-Related Quality of Life (HRQOL) change from baseline to week 8 and one-month follow-up (Week 12)
Baseline, Week 6-8, Week 24
BMI change from baseline to week 6-8 and one-month follow-up (Week 12)
Baseline, post-training, Week 12
- +2 more secondary outcomes
Study Arms (2)
Intervention
EXPERIMENTALintervention participants will engage in a 30-minutes VR adventure games on a non-mobilized treadmill (5-min warm-up, 20-minutes treadmill, and 5-min cool-down) for a total of 6 sessions over 6-8 weeks. Participants in the V-RATE group will be instructed to self-pace walking/running on the treadmill while they are fully immersed in the VR games for two 10-minute bouts with a complete rest interval (heart rate reduces to normal range). Participants will complete measures at baseline, post-training, and one-month follow-up.
Control
NO INTERVENTIONControl participants will not receive the intervention. Participants will complete measures at baseline, post-training, and one-month follow-up.
Interventions
The V-RATE intervention will be delivered through a 360-degree non-mobilized treadmill in a university clinical laboratory for 6-8-weeks (1-2 days/week, 30 minutes/session) totaling 6 sessions. The V-RATE program will be focused on creating a safe and immersive environment supportive of physical activity. The treadmill enables an individual can walk and run at self-paced speed, moving in 360-degrees (i.e., forwards, sideways, and backwards) without risk of falling. The core feature of the self-paced treadmill is a concave walking platform with an adjustable waist hardness that enables a safe, smooth, natural gait while adults with elevated BMI engage in an immersive walking and running motion. During the V-RATE intervention, participants will self-pace their locomotor action (walking/running/bending/ jumping) while they wear the VR headset and experience immersive VR adventure games using the Omniverse VR system.
Eligibility Criteria
You may qualify if:
- Are between the ages of 18 and 45
- Identify as a U.S. military veteran
- \. Normal vision (no colorblindness)
You may not qualify if:
- Unable to walk independently (e.g., use of any mobility assistive device such as brace, wheelchair, cane, crutch, walker, knee scooter)
- Self-reported joint problem that limits mobility (e.g., arthritis or other condition that would prevent participation) or ongoing orthopedic injury
- Self-reported pregnancy or suspicion of pregnancy
- Self-reported motor disorder or impaired sense of motion or balance (such as Parkinsonism)
- Self-reported color blindness
- Self-reported neurological or cognitive disorder (e.g., TBI, history of seizure)
- Self-reported cardiac surgery or any ongoing cardiovascular issues preventing participation or physical activity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Texas at Arlington
Arlington, Texas, 76019, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 28, 2022
First Posted
October 3, 2022
Study Start
September 7, 2022
Primary Completion (Estimated)
August 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
October 29, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share